These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

298 related items for PubMed ID: 4201582

  • 1. Australia antigen and circulating antibodies in chronic aggressive hepatitis.
    Findor J, Igartua EB, Alonso A, Domecq R, Bozzola C.
    Acta Hepatogastroenterol (Stuttg); 1973; 20(2):98-102. PubMed ID: 4201582
    [No Abstract] [Full Text] [Related]

  • 2. [Differentiation of chronic forms of hepatitis by immunological methods].
    Asamer H, Judmaier G, Stühlinger W, Platzer S, Födisch HJ, Spath P, Huber H.
    Wien Klin Wochenschr; 1973 Jul 06; 85(27):485-9. PubMed ID: 4578038
    [No Abstract] [Full Text] [Related]

  • 3. [Australia antigen in chronic aggressive hepatitis and liver cirrhosis. Its significance for the etiology and pathogenesis of chronic inflammatory liver diseases].
    Müller R, Kalden JR, Baruth B, Deicher H.
    Dtsch Med Wochenschr; 1972 Mar 10; 97(10):369-75. PubMed ID: 4622158
    [No Abstract] [Full Text] [Related]

  • 4. [Possible use of immunofluorescence in chronic agressive hepatitis].
    Storch W, Emmrich R.
    Dtsch Z Verdau Stoffwechselkr; 1973 Mar 10; 33(3):119-23. PubMed ID: 4599279
    [No Abstract] [Full Text] [Related]

  • 5. [Immunopathogenesis of chronic inflammatory liver diseases].
    Meyer zum Büschenfelde.
    Ergeb Inn Med Kinderheilkd; 1972 Mar 10; 32():31-81. PubMed ID: 4556562
    [No Abstract] [Full Text] [Related]

  • 6. "Autoallergic" hepatitis.
    Doniach D, Walker JG, Roitt IM, Berg PA.
    N Engl J Med; 1970 Jan 08; 282(2):86-8. PubMed ID: 4902931
    [No Abstract] [Full Text] [Related]

  • 7. [Clinical significance of the study of antibodies and complement in chronic hepatopathies].
    Naccarato R, Farini R, Chiaramonte M.
    Minerva Med; 1978 Aug 18; 69(38):2573-9. PubMed ID: 309566
    [No Abstract] [Full Text] [Related]

  • 8. [Detection of Australia antigen and corresponding antibodies during different diseases of the liver. Comparison of the technics used].
    Lavillaureix L, Cvoric M, Lautier F, Stahl J.
    Nouv Presse Med; 1973 Mar 03; 2(9):580. PubMed ID: 4634051
    [No Abstract] [Full Text] [Related]

  • 9. [Autoantibodies and Australia antigen in acute and chronic liver].
    Fargion SR, Del Ninno E, Cappellini MD, Fiorelli G.
    Minerva Med; 1974 Feb 21; 65(13):723-8. PubMed ID: 4545217
    [No Abstract] [Full Text] [Related]

  • 10. [Immunopathogenetic aspects of chronic hepatitis].
    Storch W.
    Z Gesamte Inn Med; 1977 Feb 01; 32(3):65-70. PubMed ID: 300953
    [Abstract] [Full Text] [Related]

  • 11. Immunological factors in the evolution of active chronic hepatitis and other autoimmune liver diseases.
    Smith MG, Eddleston AL, Williams R.
    Clin Gastroenterol; 1975 May 01; 4(2):297-313. PubMed ID: 1092487
    [No Abstract] [Full Text] [Related]

  • 12. [Chronic hepatitis. New classification and clinical criteria].
    Del Prete S, Malacco E, Ucelli S, Doniach D, Dane DS, Walsh JH.
    Recenti Prog Med; 1974 May 01; 56(3):193-211. PubMed ID: 4207539
    [No Abstract] [Full Text] [Related]

  • 13. Incidence of hepatitis associated antigen in chronic liver disease in Southern Italy.
    Del Vecchio-Blanco C, Carrella M, Coltorti M.
    Acta Hepatogastroenterol (Stuttg); 1973 May 01; 20(2):138-42. PubMed ID: 4356375
    [No Abstract] [Full Text] [Related]

  • 14. Immunoglobulins, glycoproteids and Australia antigen in chronic liver disease.
    Fehér J, Jakab L, Szilvási I.
    Acta Med Acad Sci Hung; 1973 May 01; 30(3):197-203. PubMed ID: 4132109
    [No Abstract] [Full Text] [Related]

  • 15. [Significance of immune histological findings for indication of immunosuppressive therapy in chronic aggressive hepatitis].
    Storch W, Emmrich R, Petzold H.
    Z Gesamte Inn Med; 1973 Jun 01; 28(11):Suppl:174-6. PubMed ID: 4580507
    [No Abstract] [Full Text] [Related]

  • 16. [Significance of anti-tissue antibodies in the evolution of chronic liver diseases].
    Buligescu L, Moscaliuc I, Eşanu I, Ionică M.
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1981 Jun 01; 33(6):445-52. PubMed ID: 6121363
    [No Abstract] [Full Text] [Related]

  • 17. Detection of hepatitis-B antigen by radioimmunoassay in chronic liver disease and hepatocellular carcinoma in Great Britain.
    Reed WD, Stern RB, Eddleston AL, Williams R, Zuckerman AJ, Bowes A, Earl PM.
    Lancet; 1973 Sep 29; 2(7831):690-4. PubMed ID: 4125788
    [No Abstract] [Full Text] [Related]

  • 18. Occurrence of Australia antigen in chronic hepatitis in Italy.
    Bianchi P, Porro CB, Coltorti M, Dardanoni L, Del Vecchio Blanco C, Fagiolo U, Farini R, Menozzi I, Naccarato R, Pagliaro L, Spanò C, Verme G.
    Gastroenterology; 1972 Sep 29; 63(3):482-5. PubMed ID: 4627200
    [No Abstract] [Full Text] [Related]

  • 19. Significance of serum complement levels in chronic liver disease.
    Finlayson ND, Krohn K, Fauconnet MH, Anderson KE.
    Gastroenterology; 1972 Oct 29; 63(4):653-9. PubMed ID: 4116547
    [No Abstract] [Full Text] [Related]

  • 20. Immunologic aspects of liver disease.
    Paronetto F.
    Postgrad Med; 1973 Jan 29; 53(1):156-60. PubMed ID: 4539233
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.